221 related articles for article (PubMed ID: 36816953)
1. Targeting
Bromfield JI; Hugenholtz P; Frazer IH; Khosrotehrani K; Chandra J
Front Oncol; 2023; 13():1091379. PubMed ID: 36816953
[TBL] [Abstract][Full Text] [Related]
2. Reduced Staphylococcus Abundance Characterizes the Lesional Microbiome of Actinic Keratosis Patients after Field-Directed Therapies.
Kehrmann J; Koch F; Zumdick S; Höwner A; Best L; Masshöfer L; Scharfenberg S; Zeschnigk M; Becker JC; Schadendorf D; Buer J; Roesch A
Microbiol Spectr; 2023 Jun; 11(3):e0440122. PubMed ID: 37212689
[TBL] [Abstract][Full Text] [Related]
3. A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes.
Wood DLA; Lachner N; Tan JM; Tang S; Angel N; Laino A; Linedale R; Lê Cao KA; Morrison M; Frazer IH; Soyer HP; Hugenholtz P
mBio; 2018 Oct; 9(5):. PubMed ID: 30301852
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the skin microbiome in normal and cutaneous squamous cell carcinoma affected cats and dogs.
Bromfield JI; Zaugg J; Straw RC; Cathie J; Krueger A; Sinha D; Chandra J; Hugenholtz P; Frazer IH
mSphere; 2024 Apr; 9(4):e0055523. PubMed ID: 38530017
[TBL] [Abstract][Full Text] [Related]
5. Skin Microbiome Variation with Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.
Voigt AY; Emiola A; Johnson JS; Fleming ES; Nguyen H; Zhou W; Tsai KY; Fink C; Oh J
J Invest Dermatol; 2022 Oct; 142(10):2773-2782.e16. PubMed ID: 35390349
[TBL] [Abstract][Full Text] [Related]
6. Secreted Toxins From
Krueger A; Zaugg J; Chisholm S; Linedale R; Lachner N; Teoh SM; Tuong ZK; Lukowski SW; Morrison M; Soyer HP; Hugenholtz P; Hill MM; Frazer IH
Front Microbiol; 2021; 12():789042. PubMed ID: 35145494
[TBL] [Abstract][Full Text] [Related]
7. Profiling of microRNAs in actinic keratosis and cutaneous squamous cell carcinoma patients.
Dańczak-Pazdrowska A; Pazdrowski J; Polańska A; Basta B; Schneider A; Kowalczyk MJ; Golusiński P; Golusiński W; Adamski Z; Żaba R; Masternak MM
Arch Dermatol Res; 2022 Apr; 314(3):257-266. PubMed ID: 33813600
[TBL] [Abstract][Full Text] [Related]
8. Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients.
Shibayama Y; Imafuku S
J Dermatol; 2014 Dec; 41(12):1102-5. PubMed ID: 25385075
[TBL] [Abstract][Full Text] [Related]
9. Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients.
Krueger A; Zaugg J; Lachner N; Bialasiewicz S; Lin LL; Gabizon S; Sobarun P; Morrison M; Soyer HP; Hugenholtz P; Frazer IH
ISME Commun; 2022 Feb; 2(1):13. PubMed ID: 37938715
[TBL] [Abstract][Full Text] [Related]
10. Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
Rymsza A; Świerczyńska K; Piotrowska A; Dzięgiel P; Szepietowski JC
In Vivo; 2022; 36(3):1245-1251. PubMed ID: 35478139
[TBL] [Abstract][Full Text] [Related]
11. Skin Cancer-Associated
Krueger A; Mohamed A; Kolka CM; Stoll T; Zaugg J; Linedale R; Morrison M; Soyer HP; Hugenholtz P; Frazer IH; Hill MM
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565272
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
13. OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma.
Murata M; Ito T; Tanaka Y; Yamamura K; Furue K; Furue M
J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32106476
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.
Azimi A; Kaufman KL; Ali M; Arthur J; Kossard S; Fernandez-Penas P
J Dermatol Sci; 2018 Jul; 91(1):69-78. PubMed ID: 29665991
[TBL] [Abstract][Full Text] [Related]
15. Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen's Disease and Squamous Cell Carcinoma: A Proposal.
Molina-García M; Malvehy J; Granger C; Garre A; Trullàs C; Puig S
Dermatol Ther (Heidelb); 2022 Feb; 12(2):361-380. PubMed ID: 35112326
[TBL] [Abstract][Full Text] [Related]
16. Genetic Studies of Actinic Keratosis Development: Where Are We Now?
Lee YB; Kim JI
Ann Dermatol; 2023 Dec; 35(6):389-399. PubMed ID: 38086352
[TBL] [Abstract][Full Text] [Related]
17. Molecular Profiling of Keratinocyte Skin Tumors Links
Madhusudhan N; Pausan MR; Halwachs B; Durdević M; Windisch M; Kehrmann J; Patra V; Wolf P; Boukamp P; Moissl-Eichinger C; Cerroni L; Becker JC; Gorkiewicz G
Cancers (Basel); 2020 Feb; 12(3):. PubMed ID: 32111012
[TBL] [Abstract][Full Text] [Related]
18. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
19. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus.
Bjerre RD; Holm JB; Palleja A; Sølberg J; Skov L; Johansen JD
BMC Microbiol; 2021 Sep; 21(1):256. PubMed ID: 34551705
[TBL] [Abstract][Full Text] [Related]
20. Advancements in elucidating the pathogenesis of actinic keratosis: present state and future prospects.
Wang Z; Wang X; Shi Y; Wu S; Ding Y; Yao G; Chen J
Front Med (Lausanne); 2024; 11():1330491. PubMed ID: 38566927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
